Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Thoracic 1Gynecologic 1Dermatologic 1CNS 1Breast 1

Conditions

Breast Neoplasms 26Ovarian Neoplasms 12Carcinoma, Non-Small-Cell Lung 10Triple Negative Breast Neoplasms 7Melanoma 7Pancreatic Neoplasms 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Neoplasm Metastasis 5Urogenital Neoplasms 4Stomach Neoplasms 4Lung Neoplasms 4Carcinoma, Ovarian Epithelial 4Small Cell Lung Carcinoma 3Sarcoma 3Lymphoma 3Kidney Neoplasms 3Carcinoma, Renal Cell 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neuroblastoma 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Inflammatory Breast Neoplasms 2Hodgkin Disease 2

Interventions

Cyclophosphamide 3pembrolizumab 1fludarabine 1aldesleukin 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Mass Spectrometry 1Interleukin-2 1Immunotherapy 1Imatinib Mesylate 1Drug Therapy 1Chromatography, High Pressure Liquid 1Biological Therapy 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Synovial × aldesleukin × Breast × Clear all
NCT05296564 2025-10-02

Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers

Hadassah Medical Organization

Phase 1/2 Recruiting
3 enrolled
BreastCNSDermatologicGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasm Metastasis, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Sarcoma, Synovial, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡